Experimental and clinical data support a role for estrogens in the development and 23 growth of breast cancer, and lowered estrogen exposure reduces breast cancer recurrence and 24 new diagnoses in high-risk women. There is varied evidence that increased physical activity is 25 associated with breast cancer risk reduction in both pre-and postmenopausal women, perhaps via 26 lowered estrogen levels. The purpose of this study was to assess whether exercise intervention in 27 premenopausal women at increased breast cancer risk reduces estrogen or progesterone levels. 28
INTRODUCTION 44
Experimental and clinical data support a role for estrogens in the development and 45 growth of breast cancer, with the primary hypothesis being that estrogens interact with receptors 46 in a manner that increases cell proliferation rates (7, 70). Lowering endogenous estrogen levels 47 via bilateral oopherectomy or blocking estrogen effects with selective estrogen receptor 48 modulators (SERMS) such as tamoxifen and raloxifene reduce the rate of initial diagnoses 49 among women at high risk of developing breast cancer (11, 29, 38, 34, 36, 55) . Early onset of 50 menarche, late first full-term pregnancy, and late menopause -factors that increase lifetime 51 estrogen exposure -have all been associated with higher rates of breast cancer. On the other 52 hand, there is conflicting epidemiologic evidence of a link between premenopausal endogenous 53 estrogens and breast cancer risk. Of seven studies identified, four observed a significant inverse 54 association of endogenous estrogens with breast cancer risk in premenopausal women (12, 28, 55 56, 34), while three others did not (21, 27, 69) . 56
In contrast to estrogens, progesterone has long been thought to have an anti-proliferative 57 effect in the premenopausal breast, analogous to its opposition to estrogen-induced epithelial 58 proliferation in the endometrium of the luteal phase of the menstrual cycle (16). Epidemiologic 59 data are both supportive (27, 48, 59) and not supportive (13, 21, 69) of progesterone's protective 60 effects, and there are animal data that implicate progesterone in mammary endothelial 61 proliferation (23). The conflicting findings may result from alteration of the relationship of 62 progesterone to mammary gland morphogenesis and function that occurs with full-term 63 pregnancy, which may explain the protective effect of early age at first full-term pregnancy (45) . 64
In any case, however, breast mitotic activity is in fact highest during the luteal phase of the 65 menstrual cycle, when progesterone levels are also highest. 66 4.
Just as there is considerable support for a role of estrogens in the pathogenesis of breast 67 cancer, there is wide-ranging evidence -including prospective cohort investigations in breast 68 (39) , colorectal (38), endometrial (16), lung (37), ovarian (40), and prostate cancer (26) -that 69 increased levels of physical activity are associated with a reduction in cancer risk, including 70 breast cancer risk (33, 35, 60, 65). The hypothesized mechanisms by which exercise reduces 71 breast cancer risk are varied and complex, but evidence is accumulating that aerobic activity 72 results in a negative energy balance (41) and lowers estrogen levels in both pre-and 73 postmenopausal women (5, 9, 66). At the extreme in premenopausal women, exercise of 74 significant frequency and intensity that is associated with a negative energy balance can lead to 75 longer menstrual cycles and menstrual dysfunction (e.g., luteal phase deficiency (8), anovulatory 76 cycles (5), and amenorrhea (66, 67), but moderate exercise (e.g., household and/or recreational 77 activities (39, 62)) where energy balance is maintained has been linked to a variety of health 78 benefits without disrupted menstrual or reproductive function (42, 65) . 79
Evidence of the presence, direction, and magnitude of effects of estrogen and 80 progesterone on breast cancer pathogenesis has been limited by reliance on a single or small 81 number of measurements of hormone levels as a surrogate marker for overall long-term 82 hormonal exposure. The variability in hormone levels among premenopausal women over the 83 course of the menstrual cycle makes the results of studies that use a single or only several 84 measurements less accurate than would daily measures taken over an entire menstrual cycle (47, 85 50, 61). Use of single measurements may, as a consequence, be a source of conflicting findings 86 5.
entire menstrual cycle that permit calculation of the total "area under the curve" (AUC) provide a 90 more accurate measure of overall exposure. Figure 1 depicts two hypothetical estradiol exposure 91 curves across a single menstrual cycle. The area under the solid line is greater than the area 92 under the dotted line, denoting greater overall estradiol exposure across the entire menstrual 93 cycle. The AUC method of assessing total hormone exposure has become the standard in studies 94 of the effect of exercise training on hormone levels and reproductive function (2, 68), but it has 95 not been used to study the effects of exercise on hormone exposure in women at high risk of 96 developing breast cancer. 97
The primary aim of the study reported here was to assess whether an exercise 98 intervention in premenopausal women at increased risk for breast cancer reduces area-under-the-99 curve estrogen levels overall and, more specifically, within the follicular, the luteal, or both 100 phases of the menstrual cycle. The study is innovative in its (1) focus on women at substantially 101 increased risk of breast cancer and (2) application of daily measurement of urinary hormone 102 levels developed for studies of the effects of exercise training on reproductive function to the 103 study of breast cancer risk reduction. The significance of the study lies in its suggestion of a 104 preventive intervention to reduce breast cancer rates in high-risk premenopausal women that may 105 be more acceptable than currently available surgical (bilateral mastectomy, oophorectomy (10)) 106 and drug therapy techniques (51), all of which have serious, long-term side effects (12, 64 Pennsylvania after Institutional Review Board approval of the study. Women were eligible if 120 they had intact ovaries and a uterus and had not had prophylactic mastectomy; gynecologic age 121 of at least 4 years (gynecologic age = current age -age of menarche) in order to increase the 122 likelihood of relatively stable menstrual cycle lengths; no history of physician-diagnosed 123 gynecological problems (e.g., fibroids, endometriosis, polycystic ovary syndrome); prior tubal 124 ligation or willingness to use a non-hormonal form of contraception during study participation 125 and no hormonal contraception use with the past 3 months; no medical conditions or medications 126 that would prohibit participation in aerobic exercise; no history of cancer, excepting non-127 melanoma skin cancer and in situ cervical cancers; BMI of at least 21 but not more than 50; no 128 current diagnosis of eating disorders; not currently participating in any weight loss programs; not 129 currently or recently (past 6 months) pregnant and not planning to become pregnant during the 130 study period; non-smoker for at least the past year; no more than 7 alcoholic beverages per week; 131 leisure-time exercise energy expenditure of ≤ 500 kcals/week over the past 6 months; not 132 planning to move away from area during the period of the study. Demographic data were 133 collected only at study entry and included age, race/ethnicity including Ashkenazi Jewish 134
heritage (associated with a higher risk of BRCA1/2 mutations (12)), education, employment, 135 7.
breast cancer risk status, parity, self-reported medication use, and self-reported menstrual cycle 136 length. 137
A total of 10 women were recruited to the study and embarked on the study protocol 138 described in Fig. 2 lasting 7 menstrual cycles. Three women did not remain in the study to 139 completion -one suffered a burst ovarian cyst, one due to an unusually long menstrual cycle 140 upon study entry, and one for failure to collect urine samples in a way that resulted in usable data 141 -resulting in analysis of 7 participants. 142
Anthropometry, body composition, and fitness. Body height was assessed at baseline; 143 body weight was assessed at both baseline and at study end. Percentage of body fat was 144 calculated based on measurement of skin folds using a standard conversion formula (58). Body 145 mass index (BMI) was calculated from weight and height at each time point. Maximal aerobic 146 fitness was predicted based on results from a treadmill test to exhaustion using the Bruce 147
Protocol (4). Heart rate during this test is measured using 12-lead ECG monitoring. Oulu, Finland), and ongoing support from a certified fitness professional. As described in Fig. 3,  153 prescribed exercise consisted of 5 menstrual cycles of exercise with a 12-week progression to 154 300 minutes per week at 80-85% of maximum heart rate (25, 68). This is the level of aerobic 155 activity recommended by Health and Human Services for increased health benefits (62). 156
Participants were instructed to work toward the weekly target minutes in no fewer than three 157 exercise sessions per week, with sessions lasting at least 15 minutes but no more than 100 158 8.
minutes. Exercise training sessions took place at the homes of the participants and included use 159 of the downloadable Polar Heart Rate monitor and instructions not to exceed 85% of age 160 predicted maximal heart rate during exercise sessions. A certified fitness professional visited 161 participants' homes for the first exercise session of each of the first 5 weeks (for a total of five 162 visits per participant across the exercise intervention) to help individualize the duration and 163 intensity of the exercise session and to instruct participants in the use of exercise logs and injury 164 prevention. Thereafter, participants were invited to attend weekly exercise sessions at 165 participating YMCAs. The Polar Heart Rate monitors were downloaded onto a laptop every two 166 weeks during a research staff person's visit to the participant's home. The certified fitness 167 professional reviewed heart rate files with the participant and discussed the need for revising 168 workout schedule or intensity based on the objectively monitored heart rate response, not based 169 on absolute work on a specific treadmill. Adherence to prescribed exercise was assessed by 170 calculating the ratio of minutes actually spent on the treadmill (summed across all exercise 171 weeks) to the minutes prescribed for each participant. 172
Urine collection and measurement and analysis of hormone levels. Participants 173 performed urine collections by saturating a sponge which was placed in an air-tight vial at the 174 first urine void every morning during two consecutive menstrual cycles. This method was 175 validated by O'Connor et al. (52) and has been associated with a 96% compliance rate, higher 176 than that seen with standard urine collection cups. Participants stored the sponge collection 177 devices in the freezer section of their home refrigerator (-4°C) for weekly pickup and delivery on 178 dry ice to the University of Pennsylvania. Samples were stored in a -80°C freezer prior to 179 shipping to Pennsylvania State University, and then stored at -20°C until analysis. Samples were 180 unfrozen and aliquotted into 2 mL tubes (6 aliquots per daily sample, 1800 µL per tube). Any 181 9.
samples containing sediment were centrifuged at 3000 rpm for 15 minutes prior to aliquotting. 182
Microtiter plate competitive enzyme immunoassays (EIA) were used to measure the urinary 183 metabolites of estrogen (estrone-1-glucuronide, E1G) and progesterone (pregnanediol-3-184 glucuronide, PdG). The secretion of these urinary metabolites parallels serum concentrations of 185 the parent hormones (43) 
RESULTS

217
The baseline characteristics of the study population are summarized in Table 1 . Of the 3 218 participants tested for BRCA1/BRCA2 mutations, all were positive (42.9% overall); of the 4 not 219 tested, 3 (42.9% overall) had a prior probability of a BRCA mutation of 50% and 1 (14.3% 220 overall) had a prior probability of 25%. Claus model scores among the study participants range 221 from 16.5% to 39.9%, with a mean of 23.5%. 222
Anthropometry, body composition, and fitness. Body composition and fitness results are 223 summarized in Table 2 . Participants showed statistically significant declines in body weight (P 224 = 0.025), BMI (P = 0.025) and body fat percentage (P = 0.02). Five participants (71%) had 225 healthy weights (BMI 18.5 -24.9) at the start of the study, while two (29%) were obese (BMI ≥ intervention, but both estrogen (P = 0.03) and progesterone (P = 0.05) levels, as assessed by the 241 AUC of urinary E1G and PdG conjugates, respectively, declined significantly with the exercise 242 intervention, as shown in Table 3 . A post-hoc power analysis was conducted (β = 80%, α = 243 0.05, two-sided) for total estrogen and progesterone AUC; their powers (1 -β error probability, 244 or sensitivity), respectively, were 0.42 and 0.32. When the AUC for E1G and PdG were 245 examined for the follicular and luteal phases separately, the changes noted for the overall cycle 246 were mostly reflective of effects on the luteal phase rather than the follicular phase. The exercise intervention evaluated in this small study reduced total estrogen exposure by 253 18.9% and total progesterone exposure by 23.7% in premenopausal women at high risk of 254 developing breast cancer. These changes are reflective of largely luteal phase effects: overall 255 estrogen exposure during the follicular and luteal phases declined 6.8% and 30.3%, respectively 256 and overall progesterone exposure declined by 21.6% and 25.7%, respectively. Placing these 257 changes into context is challenging, given that there is no established "safe" level of estrogen or 258 progesterone exposure among premenopausal high-risk women. While this study looked solely 259 at urine hormone levels rather than plasma hormone levels, current findings add to those from 260 the Nurses' Health Study that women with a three-fold increased risk of ER+/PR+ breast cancer 261 had 35% higher luteal phase plasma estradiol levels than woman at lower breast cancer risk (13). 262
The small sample size and absence of a true control group are limitations of the study that 263 require that the results be regarded as preliminary. Nonetheless, the current findings establish 264 the merit of a larger trial of the study hypothesis. They also demonstrate the feasibility of using 265 daily urine samples and AUC measurement to assess total exposure to ovarian hormones in 266 experimental studies of the impact of interventions on ovarian hormones in high-risk patients. 267
Because AUC measurement is a better indicator of total hormone exposure than are single or 268 even several assessments per cycle, the measures used in this study are likely to be more 269 reflective of overall hormonal exposure than what has been measured in prior epidemiologic 270 studies of the relationship between pre-diagnostic hormone levels and subsequent risk for breast 271 cancer in pre-menopausal women. By reducing a source of measurement error, this superior 272 13. metric may help clarify conflicting findings on the relationship between hormone levels and 273 breast cancer, including whether progesterone levels have a net proliferative or protective effect 274 on breast cancer risk in premenopausal women. 275
It is worth noting that none of the women in the study chose to attend the weekly group 276 exercise sessions at YMCAs. This finding is consistent with the hypothesis supporting at-home 277 exercise for maximizing adherence both in studies of the impact of exercise on outcomes of 278 interest as well as when exercise is recommended as a clinical intervention (24, 32, 53, 57). 279
There are, of course, many questions that must eventually be answered to provide sound 280 evidence-based guidance about optimal exercise intervention for premenopausal women at high 281 risk of developing breast cancer. For example, how do hormone levels vary with lower versus 282 higher exercise "dose," that is, how much exercise is needed to have a beneficial effect on 283 estrogen levels (and ultimately breast cancer risk reduction) and can that level be reached 284 without compromising reproductive function or bone health? Will longer-term and/or higher-285 intensity exercise produce menstrual disturbances such as anovulatory cycles or amenorrhea? 286
Was the caloric deficit produced in this study caused solely through exercise or were dietary 287 changes an independent source of weight loss and hormonal changes? Although the current 288 study is not able to address these questions, the hope is that reduction in endogenous estrogen 289 levels in high-risk women will lower breast cancer risk and improve long-term outcomes. 290
Not all women at elevated risk develop breast cancer and it is acknowledged that there 291 are non-genetic, environmental aspects to neoplastic development among those with elevated 292 risk. Nonetheless, the strongest basis for breast cancer prevention among women with elevated 293 risk is through hormonal intervention. (46, 63, 64) However, both surgical and pharmacologic 294 preventive techniques have serious negative long-term consequences that may be unacceptable to 295 14. many women. The results of this study suggest potential value in exercise interventions that 296 might address the same hormonal issues, but with fewer serious side effects and less deleterious 297 impact on quality of life. High-risk women who are highly motivated to reduce their risk may 298 benefit from knowing the degree of risk reduction they can reasonably expect from exercise, 299 even if the benefits consist only of delayed onset, lower stage at diagnosis, or reduced breast 300 density that improves detection in early screening (1, 3, 22, 31, 43) . Exercise may offer high-301 risk women a way to reduce hormone levels and would improve their overall fitness (reducing 302 weight, BMI, and body fat percentage, and increasing maximal aerobic fitness), making them 303 better prepared physically and psychologically for the rigors of therapy that would follow a 304 breast cancer diagnosis. 305
ACKNOWLEDGEMENT 306
We thank the staff for the project for their efforts, including Amy Rogerino, MPH; Lorita Grant, 307 21. heart rate (HR) maximum) of exercise to a maintenance level after week 12 of 300 minutes per 574 week at between 80% and 85% of maximum target heart rate. 575 576 577 578 22. 
FIGURE LEGENDS
